AlgoDx
AlgoDx is a precision medicine company focused on developing and implementing clinically validated Machine Learning (ML)-based clinical decision support software for intensive and critical care. Their solutions aim to save lives and reduce costs in healthcare. AlgoDx's platform addresses key medical questions: current patient status, near-future predictions, and actionable insights for outcome improvement. The company has achieved FDA clearance for its sepsis detection software, NAVOY CDS®, targeting the U.S. market, and holds CE marking for its NAVOY® Sepsis product in Europe. AlgoDx partners with leading healthcare providers and technology companies like Philips, and its technology has been featured in scientific publications and presented at industry conferences. They are recognized for their innovative approach, having received awards and recognition as a top startup in Sweden and Europe.
AlgoDx
AlgoDx is a precision medicine company focused on developing and implementing clinically validated Machine Learning (ML)-based clinical decision support software for intensive and critical care. Their solutions aim to save lives and reduce costs in healthcare. AlgoDx's platform addresses key medical questions: current patient status, near-future predictions, and actionable insights for outcome improvement. The company has achieved FDA clearance for its sepsis detection software, NAVOY CDS®, targeting the U.S. market, and holds CE marking for its NAVOY® Sepsis product in Europe. AlgoDx partners with leading healthcare providers and technology companies like Philips, and its technology has been featured in scientific publications and presented at industry conferences. They are recognized for their innovative approach, having received awards and recognition as a top startup in Sweden and Europe.
TL;DR
Focus: ML-based clinical decision support for sepsis and other acute conditions
Flagship product: NAVOY CDS® — sepsis detection SaaMD
Regulatory status: FDA 510(k) clearance (sepsis detection software) and CE marking for NAVOY® Sepsis
Founded / HQ: Founded 2018; headquartered in Stockholm, Sweden (with a U.S. office in Cambridge, MA)
Team size (approx.): 15 employees
Seed round (Feb 26, 2020); total reported funding $650,000 USD
Company Overview
Problem Domain
Sepsis detection and management; acute condition prediction (including AKI and infection-related algorithms).
Founded
2018
Industry
Healthcare / Medical Software / Precision Medicine
Funding Track Record
$650,000.00